|
[1]
|
Siegel RL, Miller KD, Jemal A.Cancer statistics, 2016[J].CA Cancer J Clin, 2016, 66(1):7-30. doi: 10.3322/caac.21332
|
|
[2]
|
Piscuoglio S, Ng CK, Murray MP, et al.The genomic landscape of male breast cancer[J].Clin Cancer Res, 2016, 22(16):4045-4056. doi: 10.1158/1078-0432.CCR-15-2840
|
|
[3]
|
Afghahi A, Forgó E, Mitani AA, et al.Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer[J].Breast Cancer Res, 2015, 17:108. doi: 10.1186/s13058-015-0623-y
|
|
[4]
|
Horlings HM, Lai C, Nuyten DS, et al.Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients[J].Clin Cancer Res, 2010, 16(2):651-663. doi: 10.1158/1078-0432.CCR-09-0709
|
|
[5]
|
Maguire SL, Peck B, Wai PT, et al.Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model[J].J Pathol, 2016, 240 (3):315-328. doi: 10.1002/path.4778
|
|
[6]
|
Guan Y, Kuo WL, Stilwell JL, et al.Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer[J].Clin Cancer Res, 2007, 13(19):5745-5755. doi: 10.1158/1078-0432.CCR-06-2882
|
|
[7]
|
Ellsworth RE, Ellsworth DL, Patney HL, et al.Genomic alterations associated with early stages of breast tumor metastasis[J].Ann Surg Oncol, 2008, 15(7):1989-1995. doi: 10.1245/s10434-008-9902-5
|
|
[8]
|
Meng F, Liu B, Xie G, et al.Amplification and overexpression of PSCA at 8q24 in invasive micropapillary carcinoma of breast[J].Breast Cancer Res Treat, 2017, 166(2)383-392. doi: 10.1007/s10549-017-4407-1
|
|
[9]
|
Bertucci F, Finetti P, Guille A, et al.Comparative genomic analysis of primary tumors and metastases in breast cancer[J].Oncotarget, 2016, 7(19):27208-27219. http://pubmedcentralcanada.ca/pmcc/articles/PMC5053643/
|
|
[10]
|
Magbanua MJ, Sosa EV, Roy R, et al.Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients[J]. Cancer Res, 2013, 73(1):30-40. http://www.ncbi.nlm.nih.gov/pubmed/23135909
|
|
[11]
|
Magbanua MJ, Melisko M, Roy R, et al.Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis [J].Cancer Res, 2013, 73(23):7134-7143. doi: 10.1158/0008-5472.CAN-13-2051
|
|
[12]
|
Bilal E, Vassallo K, Toppmeyer D, et al.Amplified loci on chromosomes 8 and 17 predict early relapse in ER-positive breast cancers [J].PLoS One, 2012, 7(6):e38575. doi: 10.1371/journal.pone.0038575
|
|
[13]
|
Simpson PT, Reis-Filho JS, Lambros MB, et al.Molecular profiling pleomorphic lobular carcinomas of the breast:evidence for a common molecular genetic pathway with classic lobular carcinomas[J]. J Pathol, 2008, 215(3):231-244. doi: 10.1002/path.v215:3
|
|
[14]
|
Pierga JY, Reis-Filho JS, Cleator SJ, et al.Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy[J].Br J Cancer, 2007, 96(2):341-351. doi: 10.1038/sj.bjc.6603483
|
|
[15]
|
Dieci MV, Smutná V, Scott V, et al.Whole exome sequencing of rare aggressive breast cancer histologies[J].Breast Cancer Res Treat, 2016, 156(1):21-32. doi: 10.1007/s10549-016-3718-y
|
|
[16]
|
Loo LW, Grove DI, Williams EM, et al.Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes[J].Cancer Res, 2004, 64(23):8541-8549. doi: 10.1158/0008-5472.CAN-04-1992
|
|
[17]
|
Shen L, O'Shea JM, Kaadige MR, et al.Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP[J]. Proc Natl Acad Sci U S A, 2015, 112(17):5425-5430. doi: 10.1073/pnas.1501555112
|
|
[18]
|
Garcia-Closas M, Hall P, Nevanlinna H, et al.Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics[J].PLoS Genet, 2008, 4(4):e1000054. doi: 10.1371/journal.pgen.1000054
|
|
[19]
|
Long J, Shu XO, Cai Q, et al.Evaluation of breast cancer susceptibility loci in Chinese women[J].Cancer Epidemiol Biomarkers Prev, 2010, 19(9):2357-2365. doi: 10.1158/1055-9965.EPI-10-0054
|
|
[20]
|
Campa D, Kaaks R, Le Marchand L, et al.Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium[J].J Natl Cancer Inst, 2011, 103(16): 1252-1263. doi: 10.1093/jnci/djr265
|
|
[21]
|
Zhang Z, Zhu Z, Zhang B, et al.Frequent mutation of rs13281615 and its association with PVT1 expression and cell proliferation in breast cancer[J].J Genet Genomics, 2014, 41(4):187-195. doi: 10.1016/j.jgg.2014.03.006
|
|
[22]
|
Shi J, Zhang Y, Zheng W, et al.Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer[J]. Int J Cancer, 2016, 139(6):1303-1317. doi: 10.1002/ijc.v139.6
|
|
[23]
|
Silvestri V, Rizzolo P, Scarnò M, et al.Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and14q24.1:results from a multicenter study in Italy[J].Eur J Cancer, 2015, 51(16):2289-2295. doi: 10.1016/j.ejca.2015.07.020
|
|
[24]
|
Li Q, Seo JH, Stranger B, et al.Integrative eQTL-based analyses reveal the biology of breast cancer risk loci[J].Cell, 2013, 152(3):633- 641. doi: 10.1016/j.cell.2012.12.034
|
|
[25]
|
Baxter JS, Leavy OC, Dryden NH, et al.Capture Hi-C identifies putative target genes at 33 breast cancer risk loci[J].Nat Commun, 2018, 9(1):1028. http://europepmc.org/abstract/MED/29531215
|
|
[26]
|
Zhang Z, Zhou C, Chang Y, et al.Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer[J].Cancer Lett, 2016, 376(1):62-73. doi: 10.1016/j.canlet.2016.03.022
|
|
[27]
|
Cao K, Li M, Miao J, et al.CCDC26 knockdown enhances resistance of gastrointestinal stromal tumor cells to imatinib by interacting with c-KIT[J].Am J Transl Res, 2018, 10(1):274-282. http://europepmc.org/abstract/MED/29423012
|
|
[28]
|
Ahmadiyeh N, Pomerantz MM, Grisanzio C, et al.8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC[J].Proc Natl Acad Sci U S A, 2010, 107(21):9742- 9746. doi: 10.1073/pnas.0910668107
|
|
[29]
|
Du M, Yuan T, Schilter KF, et al.Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome[J].Hum Mol Genet, 2015, 24(1):154-166. doi: 10.1093/hmg/ddu426
|
|
[30]
|
Grampp S, Platt JL, Lauer V, et al.Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer[J].Nat Commun, 2016, 7:13183. doi: 10.1038/ncomms13183
|
点击查看大图
下载:
